Results 191 to 200 of about 11,313 (238)

Abstract Supplement HIV Glasgow 8–11 November 2026, Glasgow, UK/Virtual

Journal of the International AIDS Society, Volume 29, Issue S6, November 2026.
wiley   +1 more source

Simultaneous versus sequential corneal cross-linking and intracorneal ring segments implantation for keratoconus: two-year study. [PDF]

Int J Ophthalmol
Omar I, Safwat Elhiny R.
europepmc   +1 more source

Effects of customized corneal cross-linking on higher-order aberrations in progressive keratoconus and low-grade myopia. [PDF]

Acta Ophthalmol
Hayek J, Viberg A, Elving S, Fredriksson A, Behndig A.   +4 more
europepmc   +1 more source

Determining the Relationship Between Corneal Stiffening and Tissue Dehydration After Corneal Cross-Linking. [PDF]

Invest Ophthalmol Vis Sci
Rodríguez-López R, Webb JN, Erdi M, Kofinas P, Franco W, Zhang H, Randleman JB, Scarcelli G.   +7 more
europepmc   +1 more source

A Novel Oxygen Chamber for Corneal Cross-Linking in a High-Oxygen Environment: A Pilot Study and Clinical Outcomes. [PDF]

J Curr Ophthalmol
Alipour F, Abbas H, Kealamakia BE, Ashrafi E, Hafezi F, Beheshtnejad AH, Ghaffari R, Dehghani S.   +7 more
europepmc   +1 more source

Assessment of Corneal Cross-Linking Effect on Progressive Keratoconus by Using the ABCD Grading System. [PDF]

Clin Ophthalmol
Alzahrani M, Alammari O, Binyamin A, Alsulami R, Hawsawi R.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Corneal Cross-Linking

Progress in Retinal and Eye Research
First introduced over 20 years ago as a treatment for progressive keratoconus, the original "Dresden" corneal cross-linking (CXL) protocol involved riboflavin saturation of the stroma, followed by 30 min of 3 mW/cm2-intensity ultraviolet-A (UV-A) irradiation.
Farhad Hafezi
exaly   +6 more sources

Corneal Cross-Linking: The Evolution of Treatment for Corneal Diseases [PDF]

Frontiers in Pharmacology, 2021
Corneal cross-linking (CXL) using riboflavin and ultraviolet A (UVA) light has become a useful treatment option for not only corneal ectasias, such as keratoconus, but also a number of other corneal diseases. Riboflavin is a photoactivated chromophore that plays an integral role in facilitating collagen crosslinking.
Farhad Hafezi, Manotosh Ray, Duoduo Wu
exaly   +4 more sources

Corneal Cross-Linking: Epi-On

Cornea, 2022
Abstract: When treating corneal ectasias, successful corneal cross-linking (CXL) requires three factors: riboflavin saturation of the corneal stroma, ultraviolet (UV) light, and oxygen. Riboflavin is too large to pass through epithelial tight junctions, so traditionally epithelial debridement is performed before riboflavin is applied making ...
openaire   +2 more sources

Corneal cross-linking

Survey of Ophthalmology, 2015
Since its inception in the late 1990s, corneal cross-linking has grown from an interesting concept to a primary treatment for corneal ectatic disease worldwide. Using a combination of ultraviolet-A light and a chromophore (vitamin B2, riboflavin), the cornea can be stiffened, usually with a single application, and progressive thinning diseases such as ...
J. Bradley Randleman, Sumitra S. Khandelwal, Farhad Hafezi   +2 more
openaire   +3 more sources